Crossmark

Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience

Crossref DOI link: https://doi.org/10.1007/s00415-025-13422-4

Published Online: 2025-10-09

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chukwuocha, Ikechukwu

Pellerin, David

Shanmugarajah, Priya

Tsironis, Theocharis

Foster, Emma

Hoggard, Nigel

Beauchamp, Nick

Turton, Lauren

McNeill, Alisdair

Brais, Bernard

Hadjivassiliou, Marios https://orcid.org/0000-0003-2542-8954
License Information

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-10-09
More Information

Article History

Received: 11 August 2025

Revised: 15 September 2025

Accepted: 22 September 2025

First Online: 9 October 2025

Declarations

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest.

Document is current

Any future updates will be listed below